Stockscreener 앱 받기
0.6689
0.86%
0.0057
시간 외 거래:
.67
0.0011
+0.16%
전일 마감가:
$0.6632
열려 있는:
$0.67
하루 거래량:
1.24M
Relative Volume:
0.51
시가총액:
$108.81M
수익:
-
순이익/손실:
$-111.13M
주가수익비율:
-0.5067
EPS:
-1.32
순현금흐름:
$-91.53M
1주 성능:
-0.25%
1개월 성능:
+5.70%
6개월 성능:
-30.65%
1년 성능:
-75.04%
1일 변동 폭
$0.6484
$0.6832
1주일 범위
$0.6423
$0.716
52주 변동 폭
$0.36
$4.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
명칭
Tenaya Therapeutics Inc
전화
415-865-2066
주소
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
TNYA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
0.6689 | 109.74M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-10 | 개시 | William Blair | Outperform |
| 2023-11-30 | 개시 | Leerink Partners | Outperform |
| 2022-06-15 | 개시 | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc 주식(TNYA)의 최신 뉴스
Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
Heart Disease Cure? Tenaya CEO Reveals Latest Therapeutic Developments at Major Growth Conference - Stock Titan
Tenaya Therapeutics shares rise 6.67% premarket after positive safety reviews for TN-201 and TN-401 gene therapy trials. - AInvest
Tenaya Therapeutics Posts Smaller Losses And Advances Gene Trials - Finimize
Tenaya (TNYA) Q2 Loss Narrows 59% - The Globe and Mail
Tenaya Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Tenaya's Gene Therapies Clear Key Safety Hurdles: Q4 Data Readouts Coming for Heart Disease Treatments - Stock Titan
What are the technical indicators suggesting about Tenaya Therapeutics Inc.Achieve consistent profits with proven methods - Jammu Links News
What analysts say about Tenaya Therapeutics Inc. stockPhenomenal wealth increase - Jammu Links News
Why is Tenaya Therapeutics Inc. stock attracting strong analyst attentionCapitalize on fast-moving stock opportunities - Jammu Links News
How strong is Tenaya Therapeutics Inc. company’s balance sheetMaximize your gains with professional insights - Jammu Links News
Does Tenaya Therapeutics Inc. stock perform well during market downturnsMarket-beating returns - Jammu Links News
What are the latest earnings results for Tenaya Therapeutics Inc.Market-leading capital gains - Jammu Links News
What is Tenaya Therapeutics Inc. company’s growth strategyCapitalize on market shifts before others do - Jammu Links News
What makes Tenaya Therapeutics Inc. stock price move sharplyMaximize gains with timely market signals - Jammu Links News
What is the dividend policy of Tenaya Therapeutics Inc. stockBoost your wealth with consistent growth stocks - Jammu Links News
How sentiment analysis helps forecast Tenaya Therapeutics Inc.ROI Focused Setup Screener With Exit Markers - Newser
Can Tenaya Therapeutics Inc. hit a new high this monthMarket Opportunity Tracker for Swing Traders - Newser
Is Tenaya Therapeutics Inc. stock bottoming outVolume Confirmed Setup with Entry Confidence - Newser
How to read the order book for Tenaya Therapeutics Inc.Free Consistent Profit Pattern Recognition Tools - Newser
Advanced analytics toolkit walkthrough for Tenaya Therapeutics Inc.Technical Confirmation System with Signal Alerts - Newser
How does Tenaya Therapeutics Inc. generate profit in a changing economyChart Pattern Strategy To Watch Now - Jammu Links News
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Average Rating of “Buy” from Analysts - Defense World
Using economic indicators to assess Tenaya Therapeutics Inc. potentialReal Market Tracker with Price Action Tools - Newser
Will Tenaya Therapeutics Inc. stock go up soonFundamental Forecast for Undervalued Stocks - Newser
What institutions are buying Tenaya Therapeutics Inc. stock nowFundamental Forecast for Undervalued Stocks - Newser
Intrinsic Value of Tenaya Therapeutics Inc. Stock: Is It Undervalued or OvervaluedDaily Breakout List with Smart Filters - Newser
Kalaris Therapeutics shares rise 1.49% intraday after Tenaya Therapeutics, Inc. received positive safety endorsements for its cardiovascular gene therapy clinical trials. - AInvest
Published on: 2025-07-30 22:05:21 - metal.it
Tenaya Receives Positive Safety Reviews from Independent - GlobeNewswire
Tenaya Therapeutics stock rises after positive safety reviews for heart gene therapies By Investing.com - Investing.com South Africa
Tenaya Therapeutics stock rises after positive safety reviews for heart gene therapies - Investing.com Nigeria
Gene Therapy's Cardiovascular Revolution: Why Tenaya Therapeutics Is a High-Conviction Bet in 2025 - AInvest
Tenaya completes enrollment in both dose cohorts for HCM gene therapy - Investing.com
Tenaya Receives Positive Safety Reviews from Independent DSMBs to Advance Both TN-201 and TN-401 Gene Therapy Clinical Trials as Designed - The Manila Times
Breakthrough: Tenaya's Dual Heart Disease Gene Therapies Pass Major Safety Milestone - Stock Titan
How Resilient Is Tenaya Therapeutics Inc. Stock During Economic DownturnsEarly Buy Opportunity with Chart Triggers - Newser
Will earnings trigger a reversal in Tenaya Therapeutics Inc.Real-Time AI Entry Forecast Generator - Newser
What analysts say about Tenaya Therapeutics Inc. stock outlookEntry Optimization Tool with Screener Logic - Newser
Analyzing net buyer seller activity in Tenaya Therapeutics Inc.Free Reversal Alert Based on RSI Indicator - Newser
Is it the right time to buy Tenaya Therapeutics Inc. stockEarnings Report Insights With Low Risk - jammulinksnews.com
How Tenaya Therapeutics Inc. stock performs during market volatilityFree AI Screening for Swing Trade Picks - Newser
Tenaya Therapeutics Inc (TNYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):